SHERRI ANGLIN: Open Payments
NPI 1144551284 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$735 in 37 payments from 10 companies in 2025. Trend: 2023 $550 · 2024 $476 · 2025 $735
Food & beverage: $735
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 10 | $169 |
| Vanda Pharmaceuticals Inc. | 6 | $144 |
| ABBVIE INC. | 5 | $97 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $83 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $67 |
| E.R. Squibb & Sons, L.L.C. | 3 | $56 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| Supernus Pharmaceuticals, Inc. | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: ARISTADA, VRAYLAR, CAPLYTA, HETLIOZ, TRINTELLIX, LYBALVI, FANAPT, COBENFY.
Industry payments across FL — which companies pay providers there.
